Intelligence · Clinical pipeline
Autoimmune & immunology · Phase II
Autoimmune & immunology programs at Phase II — ClinicalTrials.gov pipeline intelligence.
Quick answer
Autoimmune & immunology Phase II programs: NovaPharmaNews indexes 325 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 26 programs
- Teva Pharma 13 programs
- Lakefront Biotherapeutics NV 12 programs
- Anaxis Pharma 11 programs
- Chinese Academy of 11 programs
- Novartis India 11 programs
- Sanofi-Aventis U.S 10 programs
- Pacira Ireland 9 programs
- United Therapeutics Europe 8 programs
- RIGEL PHARMACEUTICALS 6 programs
- Regeneron UK 6 programs
- Vertex Pharmaceuticals (Australia) 6 programs
Pipeline programs
-
VTX002-201
Lacuna Pharma Pty Ltd
Moderately to Severely Active Ulcerative Colitis
1 trial -
VX-150
Vertex Pharmaceuticals (Australia) Pty.
Osteoarthritis
1 trial -
VX-702
Vertex Pharmaceuticals (Australia) Pty.
Rheumatoid Arthritis
2 trials -
VX-765
Vertex Pharmaceuticals (Australia) Pty.
Psoriasis
1 trial -
Vancomycin Pre-Treatment
Seres Therapeutics
Ulcerative Colitis
1 trial -
Vedolizumab 300 MG Injection [Entyvio]
Takeda
Immune Checkpoint Inhibitor-Related Colitis
1 trial -
Vedolizumab intravenous injection
Takeda
Ulcerative Colitis
1 trial -
Veltuzumab
Takeda
Rheumatoid Arthritis
1 trial -
Voclosporin High Dose
Aurinia Pharmaceuticals
Lupus Nephritis
1 trial -
WA42985
Hoffmann-La Roche
Lupus Nephritis (LN)
1 trial -
Xanthohumol
NORTHWEST BIOTHERAPEUTICS INC
Crohn Disease
1 trial -
ZASOCITINIB
Takeda
Moderate to Severely Active Ulcerative Colitis & Moderate to Severely Active Crohn's Disease
1 trial -
ZB012-02-001
Zenas BioPharma
Systemic Lupus Erythematosus
1 trial -
ZL-1102 1% w/w gel BID for 16 weeks
Hong Kong Baptist University
Plaque Psoriasis
1 trial -
Zanubrutinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Refractory/Relapsed Autoimmune Hemolytic Anemia
1 trial -
Zasocitinib
Takeda
Crohn's Disease
2 trials -
Zilretta
Pacira Ireland Limited
Osteoarthritis of Hip
1 trial -
Zr89
Disc Medicine
giant cell arteritis, rheumatoid arthritis
1 trial -
[68Ga]FAPI-46
Disc Medicine
giant cell arteritis - polymyalgia rheumatica spectrum disease
1 trial -
amobarbital/Gel-One (one dose)
United Therapeutics Europe Ltd
Osteoarthritis
1 trial -
bimekizumab
Lacuna Pharma Pty Ltd
Moderate to Severe Plaque Psoriasis
1 trial -
corticosteroids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Severe Colitis (ASC)
1 trial -
cyclophosphamide
Ultragenyx UK Limited
Anemia, Hemolytic, Autoimmune
1 trial -
cytarabine
Ultragenyx UK Limited
Lupus Erythematosus, Systemic
1 trial -
edratide
Teva Pharma GmbH
Systemic Lupus Erythematosus
1 trial -
etiprednol dicloacetate
Teva Pharma GmbH
Crohn's Disease
1 trial -
glatiramer acetate
Teva Pharma GmbH
Crohns Disease
1 trial -
honeybee venom (Apitoxin (Korea) Apitox (USA))
Apimeds Pharmaceuticals US
Osteoarthritis of the Knee
1 trial -
infloran
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Enterocolitis, Necrotizing
1 trial -
mesenchymal stem cell
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
nicotinamide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cutaneous Lupus Erythematosus
1 trial -
pectin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
rituximab
Chinese University of Hong Kong
Systemic Lupus Erythematosus
1 trial -
sarilumab
Sanofi-aventis Healthcare Pty Ltd
Systemic Juvenile Idiopathic Arthritis (sJIA)
1 trial -
tulisokibart, Placebo to MK-7240
Merck Sharp and Dohme
Psoriatic arthritis
1 trial -
tulisokibart, Placebo to MK-7240 (tulisokibart)
Merck Sharp and Dohme
Rheumatoid Arthritis
1 trial -
vilamakitug
XBiotech Germany GmbH
Axial Spondyloarthritis
1 trial
Frequently asked questions
How many autoimmune & immunology Phase II programs exist?
325 programs match both the therapeutic area and stage filters in our published index.